January 20, 2022

Driving Momentum: TransCelerate’s 2021 Year in Review

Despite closing out a second year of the COVID-19 pandemic, the R&D ecosystem continued to carry its momentum to modernize clinical trials and make them even more patient-friendly, accessible, and safe. Our 20 Member Companies worked diligently together to create solutions that can transform information flow in clinical development, how sponsors and sites interact with…

Explore

January 4, 2022

TransCelerate BioPharma in the News Q4 2021

TransCelerate’s Member Company experts were featured in the press on a variety of topics throughout the last few months on a number of topics from data sharing to the ongoing pandemic. Read on to catch up on our latest news. In September, TransCelerate commenced the development of an open-source reference implementation of a study definitions…

Explore